Lampalizumab (Anti-Complement Factor D)
Product Specifications
CAS Number
1278466-20-8
Synonyms
RG 7417; TNX 234; Anti-CFD Recombinant Antibody
Additionnal Information
Lampalizumab (Anti-Complement Factor D) is a humanised monoclonal antibody targeting complement Factor D in the alternative complement pathway. Lampalizumab binds an exosite and sterically blocks Factor B access to the active site. Lampalizumab can be used for age-related macular degeneration (AMD) research. MW: 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2985930-01 20 µg
Recombinant Human Leukocyte surface antigen CD47 (CD47), partial, Biotinylated
Sign In for Pricing
View Details